Barbara Giannini

ABL Mutations in Late Chronic Phase Chronic Myeloid Leukemia Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Blast Crisis and Shorter Survival: A Study by the GIMEMA Working Party on Chronic Myeloid Leukemia

Simona Soverini, Giovanni Martinelli, Gianantonio Rosti et al. · Journal of Clinical Oncology · 2005 · 372 citations · Full text

Medicine, Hematology, Pharmacology +14

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

Simona Soverini, Caterina De Benedittis, Kateřina Machová Poláková et al. · Blood · 2013 · 162 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +14

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation

Simona Soverini, Michèle Cavo, Claudia Cellini et al. · Blood · 2003 · 120 citations · Full text

Medicine, Cancer Biology, Oncology +17

Molecular response to imatinib in late chronic-phase chronic myeloid leukemia

Gianantonio Rosti, Giovanni Martinelli, Simona Bassi et al. · Blood · 2003 · 82 citations · Full text

Medicine, Molecular Biology, Oncology +8

Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.

Marilina Amabile, Barbara Giannini, Nicoletta Testoni et al. · PubMed · 2001 · 46 citations

Life Sciences, Hematology, Molecular Biology +15